4DM
INVIA, LLC · Decision date Sep 10, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for 4DM, a software application from INVIA, LLC, on September 10, 2026, under 510(k) number K260879. The device is regulated as a medical image management and processing system under 21 CFR 892.2050, Class II, with product codes QIH and LLZ, in the radiology specialty. A 510(k) clearance is not a PMA approval.
The submission describes 4DM as software as a medical device for image review and clinical reporting of nuclear medicine, PET, CT, MR and hybrid studies, and states it does not provide diagnoses or therapeutic recommendations. The summary names Corridor4DM (K101279) as the predicate and Cvi42 (K242781) as a reference device, describing 4DM as an updated version of the predicate. The summary lists deep-learning features for cardiac isolation from CT and for volumetric blood flow images. The source does not include performance testing results or the specific changes from the predicate.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260879
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- INVIA, LLC
- Product code
- QIH
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated Radiological Image Processing Software.
- Applicant
- INVIA, LLC
- Product code
- QIH
- FDA device class
- 2
FDA decision timeline
K260879 received
Application receipt date recorded by FDA.
K260879 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Clever OneK260372 | Ewoosoft Co., Ltd. | 510(k) clearance | Nov 4, 2026 | FDA |
PeekMed webK262667 | Peek Health, S.A. | 510(k) clearance | Nov 4, 2026 | FDA |
CINA-Aneurysm+K262147 | AVICENNA.AI | 510(k) clearance | Oct 19, 2026 | FDA |
Ligence HeartK261733 | UAB Ligence | 510(k) clearance | Oct 7, 2026 | FDA |
NeuroDRK262134 | Deep Reasoning Ai, Inc. | 510(k) clearance | Oct 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
INVIA, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Ann Arbor, MI
Sources and methodology
- Original FDA record: K260879
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


